Skin and Lung Tuberculosis and Anti Tuberculosis Drug Liver Injury (ATLI)
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 108 | Views: 446

Case Studies | Medicine Science | Indonesia | Volume 6 Issue 8, August 2017 | Popularity: 6.6 / 10


     

Skin and Lung Tuberculosis and Anti Tuberculosis Drug Liver Injury (ATLI)

I Ketut Kwartantaya Winaya, I Made Suma Wirawan


Abstract: Female, 57 years old with cutaneus and lung tuberculosis lesion, came to hospital with chief of complaint nausea, and vomiting after taking an oral antituberculosis for one month. Patient with lung tuberculosis and extrapulmonary (cutaneus tuberculosis) but unknown liver cirrhotic before oral antituberculosis treatment. Laboratory results revealed increased AST, ALT, total bilirubin and decreased liver function. Patient diagnosed with cutaneus and lung tuberculosis with anti Tuberculosis drug Liver Injury (ATLI). Drugs cessation and monitoring of clinical symptoms and liver function profiles is recommended before treatment. Re-introduction and continuing ATT could be done with tight monitoring.


Keywords: antituberculosis, liver injury, ATLI, extrapulmonary tuberculosis


Edition: Volume 6 Issue 8, August 2017


Pages: 2260 - 2264



Please Disable the Pop-Up Blocker of Web Browser

Verification Code will appear in 2 Seconds ... Wait



Text copied to Clipboard!
I Ketut Kwartantaya Winaya, I Made Suma Wirawan, "Skin and Lung Tuberculosis and Anti Tuberculosis Drug Liver Injury (ATLI)", International Journal of Science and Research (IJSR), Volume 6 Issue 8, August 2017, pp. 2260-2264, https://www.ijsr.net/getabstract.php?paperid=ART20176457, DOI: https://www.doi.org/10.21275/ART20176457

Top